CA3143852A1 - Immobilized enzyme compositions for the production of hexoses - Google Patents
Immobilized enzyme compositions for the production of hexoses Download PDFInfo
- Publication number
- CA3143852A1 CA3143852A1 CA3143852A CA3143852A CA3143852A1 CA 3143852 A1 CA3143852 A1 CA 3143852A1 CA 3143852 A CA3143852 A CA 3143852A CA 3143852 A CA3143852 A CA 3143852A CA 3143852 A1 CA3143852 A1 CA 3143852A1
- Authority
- CA
- Canada
- Prior art keywords
- immobilized
- pgi
- phosphate
- composition
- enzymes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 161
- 108010093096 Immobilized Enzymes Proteins 0.000 title claims abstract description 100
- 150000002402 hexoses Chemical class 0.000 title claims abstract description 37
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims abstract description 32
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 claims abstract description 30
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 claims abstract description 24
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 claims abstract description 23
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- 229920000881 Modified starch Polymers 0.000 claims abstract description 20
- 235000019426 modified starch Nutrition 0.000 claims abstract description 20
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 19
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 19
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 19
- 229930091371 Fructose Natural products 0.000 claims abstract description 18
- 239000005715 Fructose Substances 0.000 claims abstract description 18
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 claims abstract description 17
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims abstract description 17
- 229930182830 galactose Natural products 0.000 claims abstract description 17
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract description 16
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 16
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims abstract description 16
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 16
- 229960000367 inositol Drugs 0.000 claims abstract description 16
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000002454 idoses Chemical class 0.000 claims abstract 4
- 102000004190 Enzymes Human genes 0.000 claims description 194
- 108090000790 Enzymes Proteins 0.000 claims description 194
- 238000000034 method Methods 0.000 claims description 61
- 229910019142 PO4 Inorganic materials 0.000 claims description 55
- 239000010452 phosphate Substances 0.000 claims description 54
- 102000009569 Phosphoglucomutase Human genes 0.000 claims description 51
- 108091000115 phosphomannomutase Proteins 0.000 claims description 51
- 230000008569 process Effects 0.000 claims description 49
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 37
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 37
- 238000006243 chemical reaction Methods 0.000 claims description 36
- 239000000969 carrier Substances 0.000 claims description 31
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 27
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 18
- 102000004195 Isomerases Human genes 0.000 claims description 15
- 108090000769 Isomerases Proteins 0.000 claims description 15
- 229920005989 resin Polymers 0.000 claims description 15
- 239000011347 resin Substances 0.000 claims description 15
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 claims description 13
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 claims description 13
- 239000005289 controlled pore glass Substances 0.000 claims description 12
- SLGWESQGEUXWJQ-UHFFFAOYSA-N formaldehyde;phenol Chemical compound O=C.OC1=CC=CC=C1 SLGWESQGEUXWJQ-UHFFFAOYSA-N 0.000 claims description 11
- 229920001568 phenolic resin Polymers 0.000 claims description 11
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 claims description 10
- 102000048193 Mannose-6-phosphate isomerases Human genes 0.000 claims description 10
- 229920001503 Glucan Polymers 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 102000009097 Phosphorylases Human genes 0.000 claims description 8
- 108010073135 Phosphorylases Proteins 0.000 claims description 8
- 102000004357 Transferases Human genes 0.000 claims description 8
- 108090000992 Transferases Proteins 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- 239000011022 opal Substances 0.000 claims description 8
- 101710144867 Inositol monophosphatase Proteins 0.000 claims description 7
- BGWGXPAPYGQALX-VANKVMQKSA-N alpha-D-tagatofuranose 6-phosphate Chemical compound OC[C@]1(O)O[C@H](COP(O)(O)=O)[C@H](O)[C@@H]1O BGWGXPAPYGQALX-VANKVMQKSA-N 0.000 claims description 7
- 102000006029 inositol monophosphatase Human genes 0.000 claims description 7
- 108010045211 mannose-6-phosphate phosphatase Proteins 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 108010050335 D-myo-inositol-3-phosphate synthase Proteins 0.000 claims description 6
- 108010046584 Galactose-6-phosphate isomerase Proteins 0.000 claims description 6
- GSXOAOHZAIYLCY-SRQIZXRXSA-N [(2r,3s,4r)-2,3,4,6-tetrahydroxy-5-oxohexyl] dihydrogen phosphate Chemical compound OCC(=O)[C@H](O)[C@@H](O)[C@H](O)COP(O)(O)=O GSXOAOHZAIYLCY-SRQIZXRXSA-N 0.000 claims description 6
- 239000003957 anion exchange resin Substances 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- VFRROHXSMXFLSN-KCDKBNATSA-N aldehydo-D-galactose 6-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O VFRROHXSMXFLSN-KCDKBNATSA-N 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 230000002349 favourable effect Effects 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 claims description 3
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 claims description 3
- 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 claims description 3
- VFRROHXSMXFLSN-FSIIMWSLSA-N [(2r,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O VFRROHXSMXFLSN-FSIIMWSLSA-N 0.000 claims description 3
- GBXZONVFWYCRPT-JGWLITMVSA-N [(2r,3s,4r,5r)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl] dihydrogen phosphate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)OP(O)(O)=O GBXZONVFWYCRPT-JGWLITMVSA-N 0.000 claims description 3
- 238000010523 cascade reaction Methods 0.000 claims description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims 1
- 125000001302 tertiary amino group Chemical group 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract description 17
- 229940088598 enzyme Drugs 0.000 description 180
- 229920002774 Maltodextrin Polymers 0.000 description 30
- 239000005913 Maltodextrin Substances 0.000 description 30
- 229940035034 maltodextrin Drugs 0.000 description 30
- 230000000694 effects Effects 0.000 description 29
- 150000002453 idose derivatives Chemical class 0.000 description 18
- 235000021317 phosphate Nutrition 0.000 description 17
- 229920002472 Starch Polymers 0.000 description 16
- 235000019698 starch Nutrition 0.000 description 16
- 229940041290 mannose Drugs 0.000 description 14
- -1 hexose monosaccharides Chemical class 0.000 description 13
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000008107 starch Substances 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 8
- 238000011068 loading method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 150000003512 tertiary amines Chemical group 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 239000011535 reaction buffer Substances 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 229950010772 glucose-1-phosphate Drugs 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 4
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 239000003456 ion exchange resin Substances 0.000 description 4
- 229920003303 ion-exchange polymer Polymers 0.000 description 4
- 239000011565 manganese chloride Substances 0.000 description 4
- 235000002867 manganese chloride Nutrition 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229940079919 digestives enzyme preparation Drugs 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 239000012527 feed solution Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920000193 polymethacrylate Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003335 secondary amines Chemical group 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000010364 biochemical engineering Methods 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 101100262440 Arabidopsis thaliana ECR1 gene Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920002245 Dextrose equivalent Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 108010028688 Isoamylase Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920001890 Novodur Polymers 0.000 description 1
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 1
- 229920002319 Poly(methyl acrylate) Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000003622 immobilized catalyst Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000006098 transglycosylation Effects 0.000 description 1
- 238000005918 transglycosylation reaction Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/087—Acrylic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/091—Phenol resins; Amino resins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/107—1,4-Alpha-glucan branching enzyme (2.4.1.18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2451—Glucanases acting on alpha-1,6-glucosidic bonds
- C12N9/246—Isoamylase (3.2.1.68)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01017—Mannitol-1-phosphate 5-dehydrogenase (1.1.1.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01001—Phosphorylase (2.4.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01018—1,4-Alpha-glucan branching enzyme (2.4.1.18), i.e. glucan branching enzyme
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01025—4-Alpha-glucanotransferase (2.4.1.25)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/02—Aldehyde-lyases (4.1.2)
- C12Y401/0204—Tagatose-bisphosphate aldolase (4.1.2.40)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y501/00—Racemaces and epimerases (5.1)
- C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01009—Glucose-6-phosphate isomerase (5.3.1.9)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
- C12Y504/02002—Phosphoglucomutase (5.4.2.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
- C12Y504/02006—Beta-phosphoglucomutase (5.4.2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
- C12Y504/02008—Phosphomannomutase (5.4.2.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01024—1,4-Alpha-glucan 6-alpha-glucosyltransferase (2.4.1.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01144—Tagatose-6-phosphate kinase (2.7.1.144)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y501/00—Racemaces and epimerases (5.1)
- C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
- C12Y501/03015—Glucose-6-phosphate 1-epimerase (5.1.3.15)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention relates to immobilized enzyme compositions for the preparation of a hexose. Hexoses include, for example, tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol. The invention also relates to an enzymatic process for preparing a hexose from a saccharide by contacting a starch derivative with an immobilized enzyme composition of the invention.
Description
IMMOBILIZED ENZYME COMPOSITIONS FOR THE PRODUCTION OF HEXOSES
Cross Reference to Related Applications [0001] This application claims priority to U.S. Application No. 62/875,321, filed on July 17,2019, and U.S. Application No. 62/924,323, filed on October 22, 2019, which are incorporated by reference herein in their entireties.
Field of the Invention
Cross Reference to Related Applications [0001] This application claims priority to U.S. Application No. 62/875,321, filed on July 17,2019, and U.S. Application No. 62/924,323, filed on October 22, 2019, which are incorporated by reference herein in their entireties.
Field of the Invention
[0002] The invention relates to preparation of hexose monosaccharides using immobilized enzyme compositions. More specifically, the invention relates to methods of preparing a D-hexose (or hexose) from saccharides (e.g., polysaccharides, oligosaccharides, disaccharides, sucrose, D-glucose, and D-fructose) including a step in which fructose 6-phosphate is converted to the hexose by one or more enzymatic steps catalyzed by immobilized enzymes.
Background
Background
[0003] Hexoses are monosaccharides with six carbon atoms. Hexoses include, for example, tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol.
Hexoses are used in numerous industries, clearly having a variety of applications in the pharmaceutical industry, biotechnology, and in the food and beverage industries. Hexoses may be prepared using enzymatic processes from saccharides, such as for example, monosaccharides, oligsaccharides, starch, starch derivatives, cellulose and the like. Solution-based enzymatic processes are described in published PCT applications WO 2018/169957, WO 2017/059278, and WO 2018/112139, which are incorporated herein by reference.
Hexoses are used in numerous industries, clearly having a variety of applications in the pharmaceutical industry, biotechnology, and in the food and beverage industries. Hexoses may be prepared using enzymatic processes from saccharides, such as for example, monosaccharides, oligsaccharides, starch, starch derivatives, cellulose and the like. Solution-based enzymatic processes are described in published PCT applications WO 2018/169957, WO 2017/059278, and WO 2018/112139, which are incorporated herein by reference.
[0004] The commercial development of enzymatic processes is essential for increasing the number of industrial processes that utilize green chemistry and therefore decrease the impact of synthesis on the environment Numerous enzymatic processes have been developed for commercial production (e.g., PCT applications WO 2018/169957, WO 2017/059278, and WO 2018/112139), but when these processes are for low-cost products (such as alternative sweeteners), hurdles to commercialization arise pertaining to the cost-in-use of enzyme. A common solution to this issue is the immobilization of enzymes to a carrier (e.g., WO 2016/160573). Immobilization allows for the enzyme to be reused between batches or to be used in a continuous process. The ability to reuse enzymes greatly reduces the cost-in-use of enzyme per kg of product and can be essential for commercial viability. Numerous methods for enzyme immobilization exist with no set rules for which method will be preferred by a specific process (Datta et at, Enzyme immobilization: an overview on techniques and support materials.
3 Biotech (2013), 3:1-9). Therefore, unique solutions must be developed for each process.
3 Biotech (2013), 3:1-9). Therefore, unique solutions must be developed for each process.
[0005] The enzymes in commercial processes can be adsorbed on insoluble organic or inorganic supports commonly used to improve functionality, as known in the art. These include polymeric supports such as agarose, methacrylate, polystyrene, phenol formaldehyde, or dextran, as well as inorganic supports such as glass, metal, or carbon-based materials. These materials are often produced with large surface-to-volume ratios and specialized surfaces that promote attachment and activity of immobilized enzymes. The enzymes might be affixed to these solid supports through covalent, ionic, or hydrophobic interactions. The enzymes could also be affixed through genetically engineered interactions such as covalent fusion to another protein or peptide sequence with affinity to the solid support, most often a polyhistidine sequence. The enzymes might be affixed either directly to the surface or surface coating, or they might be affixed to other proteins already present on the surface or surface coating. The enzymes can be immobilized all on one carrier, on individual carriers, or a combination of the two (e.g., two enzyme per carrier then mix those carriers).
These variations can be mixed evenly or in defined layers to optimize turnover in a continuous reactor. These enzymes may be mixed evenly or in defined layers or zones to optimize turnover. For example, the beginning of the reactor may have a layer of aGP to ensure a high initial G1P increase. Enzymes may be immobilized all on one carrier bead, each on an individual carrier bead, or in groups of enzymes on a carrier bead.
Similarly the enzymes may be immobilized on a specific carrier or multiple carriers within one process using one or more immobilization methodologies.
These variations can be mixed evenly or in defined layers to optimize turnover in a continuous reactor. These enzymes may be mixed evenly or in defined layers or zones to optimize turnover. For example, the beginning of the reactor may have a layer of aGP to ensure a high initial G1P increase. Enzymes may be immobilized all on one carrier bead, each on an individual carrier bead, or in groups of enzymes on a carrier bead.
Similarly the enzymes may be immobilized on a specific carrier or multiple carriers within one process using one or more immobilization methodologies.
[0006] There is a need to have improved processes for the production of hexoses that allows for scalability and reuseable enzyme compositions while achieving high yields of the desired hexose.
Summary of the Invention
Summary of the Invention
[0007] The invention relates to immobilized enzyme compositions for the preparation of a hexose.
Hexoses include, for example, tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol. An immobilized enzyme composition of the invention comprises, consists essentially of, or consists of at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight of the following enzymes immobilized to at least one carrier or a mixture of carriers:
a) a glucan phosphorylase (aGP), phosphoglucomutase (PGM), and optionally 14-glucan transferase (4-GT); and b) an enzyme from within a combination of enzymes selected from:
(i) phosphoglucoisomerase (P61), fructose-6-phosphate epimerase (F6PE), and tagatose-6-phosphate phosphatase (T6PP) to prepare tagatose;
(ii) phosphoglucoisomerase (PGI), piscose-6-phosphate epimerase (P6PE), and picose-6-phosphate phosphatase (P6PP) to prepare allulose;
(iii) phosphoglucoisomerase (PGI), P6PE, allose-6-phosphate isomerase (A6PI), and allose-6-phosphate phosphatase (A6PP) to prepare allose;
(iv) phosphoglucoisomerase (PGI), mannose-6-phosphate isomerase (M6PI) or phosphoglucose/phosphomannose isomerase (PGPMI), and mannose 6-phosphate phosphatase (M6PP) to prepare mannose;
(v) phosphoglucoisomerase (PGI), F6PE, galactose 6-phosphate isomerase (Gal6P1), and galactose 6-phosphate phosphatase (Gal6PP) to prepare galactose;
(vi) PGI and fructose 6-phosphate phosphatase (F6PP) to prepare fructose;
(vii) PGI, P6PE, altrose 6-phosphate isomerase (Alt6P1), and altrose 6-phosphate phosphatase (Alt6PP) to prepare altrose;
(viii) PGI, F6PE, talose 6-phosphate isomerase (Tal6P1), and talose 6-phosphate phosphatase (Tal6PP) to prepare talose;
(ix) PGI, F6PE, sorbose 6-phosphate epimerase (S6PE), and sorbose 6-phosphate phosphatase (S6PP) to prepare sorbose;
(x) PGI, F6PE, S6PE, gulose 6-phosphate isomerase (Gul6P1), and gulose 6-phosphate phosphatase (Gul6PP) to prepare gulose;
(xi) PGI, F6PE, S6PE, idose 6-phosphate isomerase (16PI), and idose 6-phosphate phosphatase (I6PP) to prepare idose; and (xii) inositol 3-phosphate synthase (IPS) and inositol monophosphatase (IMP) to prepare inositol.
In an immobilized enzyme composition of the invention the weight of each enzyme relative to the total weight of the enzymes (w/w)% ranges from 0.1% to 40%.
Hexoses include, for example, tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol. An immobilized enzyme composition of the invention comprises, consists essentially of, or consists of at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight of the following enzymes immobilized to at least one carrier or a mixture of carriers:
a) a glucan phosphorylase (aGP), phosphoglucomutase (PGM), and optionally 14-glucan transferase (4-GT); and b) an enzyme from within a combination of enzymes selected from:
(i) phosphoglucoisomerase (P61), fructose-6-phosphate epimerase (F6PE), and tagatose-6-phosphate phosphatase (T6PP) to prepare tagatose;
(ii) phosphoglucoisomerase (PGI), piscose-6-phosphate epimerase (P6PE), and picose-6-phosphate phosphatase (P6PP) to prepare allulose;
(iii) phosphoglucoisomerase (PGI), P6PE, allose-6-phosphate isomerase (A6PI), and allose-6-phosphate phosphatase (A6PP) to prepare allose;
(iv) phosphoglucoisomerase (PGI), mannose-6-phosphate isomerase (M6PI) or phosphoglucose/phosphomannose isomerase (PGPMI), and mannose 6-phosphate phosphatase (M6PP) to prepare mannose;
(v) phosphoglucoisomerase (PGI), F6PE, galactose 6-phosphate isomerase (Gal6P1), and galactose 6-phosphate phosphatase (Gal6PP) to prepare galactose;
(vi) PGI and fructose 6-phosphate phosphatase (F6PP) to prepare fructose;
(vii) PGI, P6PE, altrose 6-phosphate isomerase (Alt6P1), and altrose 6-phosphate phosphatase (Alt6PP) to prepare altrose;
(viii) PGI, F6PE, talose 6-phosphate isomerase (Tal6P1), and talose 6-phosphate phosphatase (Tal6PP) to prepare talose;
(ix) PGI, F6PE, sorbose 6-phosphate epimerase (S6PE), and sorbose 6-phosphate phosphatase (S6PP) to prepare sorbose;
(x) PGI, F6PE, S6PE, gulose 6-phosphate isomerase (Gul6P1), and gulose 6-phosphate phosphatase (Gul6PP) to prepare gulose;
(xi) PGI, F6PE, S6PE, idose 6-phosphate isomerase (16PI), and idose 6-phosphate phosphatase (I6PP) to prepare idose; and (xii) inositol 3-phosphate synthase (IPS) and inositol monophosphatase (IMP) to prepare inositol.
In an immobilized enzyme composition of the invention the weight of each enzyme relative to the total weight of the enzymes (w/w)% ranges from 0.1% to 40%.
[0008] The invention also relates to an enzymatic process for preparing a hexose from a saccharide by contacting a starch derivative with an immobilized enzyme composition of the invention under suitable reaction conditions convert the starch derivative to the hexose.
Brief Description of the Figures
Brief Description of the Figures
[0009] FIG. 1A is a graph showing the amounts of enzyme in an immobilized enzyme composition that is optimized for tagatose production.
[0010] FIG. 1B is a graph showing the amounts of enzyme in an immobilized enzyme composition in which the amounts are normalized based on the observed reaction rate of each enzyme relative to T6PP
activity in order to have equal units of activity within the cascade.
activity in order to have equal units of activity within the cascade.
[0011] FIG. 1C is a graph showing the amounts of enzyme in an immobilized enzyme composition in which the amounts were in w/w ratios of 1:1:1:1:1:1.
[0012] FIG. 2 is a graph showing the relationship of enzyme loading (w/w% of total enzyme weight/carrier weight) on the activity of an immobilized enzyme composition that is optimized for tagatose production on DUOLITE" A568. Results shown are based on relative enzymatic cascade rates with respect to a 5% loaded carrier.
Detailed Description
Detailed Description
[0013] The following description discloses the invention according to embodiments related to making and using enzymes that are immobilized to a carrier ("immobilized enzyme compositions") in processes for converting starches and starch derivatives and saccharides to hexose monosaccharides, including, for example, tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol. These processes can generally be described as enzymatic reactions that create a phosphorylated intermediate from starch, a starch derivative, or a saccharide using free phosphate (no ATP). The free phosphate is released in a highly energetically favorable final step to produce a hexose-of-interest (e.g., tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol). The phosphate is then recycled to convert additional starch, starch derivative, or a saccharide into a phosphorylated intermediate so that the process can repeat This allows for non-stoichiometric amounts of phosphate to be utilized which lowers the cost of phosphate use in the process and limits phosphate levels in waste.
[0014] Embodiments of the invention include compositions of at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight enzymes, that are immoblized on a carrier, and, which catalyze, respectively, reactions in an enzymatic process for converting a starch, starch derivative, and/or a saccharide to a hexose. An immobilized enzyme composition of the invention provides numerous advantages over their use in free solution, including: longer duration of activity (due to protection of structural features of the protein), multiple cycle reuse, and elimination of the need to remove the enzyme downstream. in addition, immobilizing enzymes on solid surfaces can work in either a stirred tank reactor, a packed bed reactor, or a rotating bed reactor; allowing flexibility in scale-up.
[0015] The enzymes contained in an immobilzed enzyme composition of the invention catalyze at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight, reactions involved in the stepwise conversion of a starch, starch derivative, or saccharides to a hexose.
The following patent publications, which are all disclosed herein in their entireties, disclose enzymatic processes, (i.e., enzyme reaction cascades) for producing hexoses in solution:
published PCT
applications WO 2018/169957, WO 2017/059278, and WO 2018/112139. Immobilized enzyme compositions of the invention, can include, but are not limited to, any of the enzymes and enzyme combinations disclosed in these references.
The following patent publications, which are all disclosed herein in their entireties, disclose enzymatic processes, (i.e., enzyme reaction cascades) for producing hexoses in solution:
published PCT
applications WO 2018/169957, WO 2017/059278, and WO 2018/112139. Immobilized enzyme compositions of the invention, can include, but are not limited to, any of the enzymes and enzyme combinations disclosed in these references.
[0016] Some immobilized enzyme compositions of the invention contain a combination of enzymes that catalyze reactions, which are common among processes for producing different hexoses, such as reaction steps leading to conversion of glucose 6-phosphate (G6P) to fructose 6-phosphate (F6P). The enzymes that catalyze these common reaction steps may be referred to as "core enzymes".
Accordingly, in some immobilized enzyme compositions of the invention, an immobilized enzyme composition at least contains the core enzymes, a glucan phosphorylase (aGP) to convert a saccharide to glucose 1-phosphate (G1P) and phosphoglucomutase (PGM) to convert G1P to glucose 6-phosphate (G6P). Enzymes in an immobilized enzyme composition of the invention, which catalyze additional reaction steps to convert 66P to various hexose products can be coimmobilized with core enzymes, or contained in separate immobilized enzyme compositions.
Accordingly, in some immobilized enzyme compositions of the invention, an immobilized enzyme composition at least contains the core enzymes, a glucan phosphorylase (aGP) to convert a saccharide to glucose 1-phosphate (G1P) and phosphoglucomutase (PGM) to convert G1P to glucose 6-phosphate (G6P). Enzymes in an immobilized enzyme composition of the invention, which catalyze additional reaction steps to convert 66P to various hexose products can be coimmobilized with core enzymes, or contained in separate immobilized enzyme compositions.
[0017] Typically, core enzymes are combined in an immobilized composition with one or more of enzymes used in the production of tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol. Accordingly, in addition to ciGP
and PGM, some immobilized enzyme compositions according to the invention also contain: (i) phosphoglucoisomerase (P61), fructose-6-phosphate epimerase (F6PE), and tagatose-6-phosphate phosphatase (T6PP) to prepare tagatose; (ii) PGI, piscose-6-phosphate epimerase (P6PE), and picose-6-phosphate phosphatase (P6PP) to prepare allulose; (iii) PG1, P6PE, allose-6-phosphate isomerase (A6PI), and allose-6-phosphate phosphatase (A6PP) to prepare allose; (iv) PGI, mannose-6-phosphate isomerase (M6PI) or phosphoglucose/phosphomannose isomerase (PGPMI), and mannose 6-phosphate phosphatase (M6PP) to prepare mannose; (v) P61, F6PE, galactose 6-phosphate isomerase (Gal6P1), and galactose 6-phosphate phosphatase (Gal6PP) to prepare galactose; (vi) PGI and fructose 6-phosphate phosphatase (F6PP) to prepare fructose; (vii) PG1, P6PE, altrose 6-phosphate isomerase (Alt6P1), and altrose 6-phosphate phosphatase (Alt6PP) to prepare altrose; (viii) PGI, F6PE, talose 6-phosphate isomerase (Tal6P1), and talose 6-phosphate phosphatase (Tal6PP) to prepare talose; (ix) PG1, F6PE, sorbose 6-phosphate epimerase (S6PE), and sorbose 6-phosphate phosphatase (S6PP) to prepare talose; (x) P61, F6PE, S6PE, gulose 6-phosphate isomerase (Gul6P1), and gulose 6-phosphate phosphatase (Gul6PP) to prepare gulose; (xi) P61, F6PE, S6PE, idose 6-phosphate isomerase (16PI), and idose 6-phosphate phosphatase (I6PP) to prepare idose; and (xii) inositol 3-phosphate synthase (UPS) and inositol monophosphatase (IMP) to prepare inositol. Each combination of core enzymes and an enzyme composition (i) ¨ (xii) are separate embodiments of the invention.
and PGM, some immobilized enzyme compositions according to the invention also contain: (i) phosphoglucoisomerase (P61), fructose-6-phosphate epimerase (F6PE), and tagatose-6-phosphate phosphatase (T6PP) to prepare tagatose; (ii) PGI, piscose-6-phosphate epimerase (P6PE), and picose-6-phosphate phosphatase (P6PP) to prepare allulose; (iii) PG1, P6PE, allose-6-phosphate isomerase (A6PI), and allose-6-phosphate phosphatase (A6PP) to prepare allose; (iv) PGI, mannose-6-phosphate isomerase (M6PI) or phosphoglucose/phosphomannose isomerase (PGPMI), and mannose 6-phosphate phosphatase (M6PP) to prepare mannose; (v) P61, F6PE, galactose 6-phosphate isomerase (Gal6P1), and galactose 6-phosphate phosphatase (Gal6PP) to prepare galactose; (vi) PGI and fructose 6-phosphate phosphatase (F6PP) to prepare fructose; (vii) PG1, P6PE, altrose 6-phosphate isomerase (Alt6P1), and altrose 6-phosphate phosphatase (Alt6PP) to prepare altrose; (viii) PGI, F6PE, talose 6-phosphate isomerase (Tal6P1), and talose 6-phosphate phosphatase (Tal6PP) to prepare talose; (ix) PG1, F6PE, sorbose 6-phosphate epimerase (S6PE), and sorbose 6-phosphate phosphatase (S6PP) to prepare talose; (x) P61, F6PE, S6PE, gulose 6-phosphate isomerase (Gul6P1), and gulose 6-phosphate phosphatase (Gul6PP) to prepare gulose; (xi) P61, F6PE, S6PE, idose 6-phosphate isomerase (16PI), and idose 6-phosphate phosphatase (I6PP) to prepare idose; and (xii) inositol 3-phosphate synthase (UPS) and inositol monophosphatase (IMP) to prepare inositol. Each combination of core enzymes and an enzyme composition (i) ¨ (xii) are separate embodiments of the invention.
[0018] The immobilized enzyme compositions, above, can also optionally contain 4-glucan transferase (4GT). 4GT can be used to increase hexose yields by recycling the degradation products glucose, maltose, and maltotriose into longer maltooligosaccharides; which can be phosphorolytically cleaved by aGP to yield G1P.
[0019] The relative weight ratios between enzymes in an immobilized enzyme composition of the invention may range from 1:1000 to 1000:1, from 1:100 to 100:1 or from 1:50 to 50:1, when comparing any two enzymes in the immobilized composition. The enzyme ratios, including other optional enzymes discussed below, can be varied to increase the efficiency of hexose production. For example, a particular enzyme may be present in an amount about 2x, 3x, 4x, 5x, 10x etc. relative to the amount of another enzyme.
[0020] Relative weight/weight ratios among the enzymes in an immobilized enzyme composition of the invention can be optimized to increase process performance and/or hexose yield. In that regard, the weight of each enzyme in an immobilized enzyme composition, relative to the total weight of the enzymes (w/w)% ranges from 0.1% to 70%. For example, some immobilized enzyme compositions of the invention contain 10-30% (aGP); 10-30% (PGM); and when present 0.1-10%
(PGI) and 0.1-10%
(4G1), when present. For example, an immobillized enzyme composition of the invention that can be used for the production of tagatose, the weight of each enzyme relative to the total weight of the enzymes (w/w)% is: 10-30% (aGP); 0-10% (4GT); 10-30% (PGM); 0.1-10% (PGI); 15-35% (F6PE); and T6PP
(25-45%), wherein the total weight of enzymes in the composition is 100 w/w%
relative to the total weight of the enzymes. Some immobilized enzyme compositions of the invention for use in tagatose production contain: 19% aGP; 3% 4GT; 17% PGM; 3% PGI; 23% F6PE; and T6PP 35%, wherein the % weight of each enzyme is relative to the total weight of the enzymes in the immobilized enzyme composition of the invention, and the total weight of enzymes in the composition is 100 w/w% relative to the total weight of the enzymes. In other examples, an immobillized enzyme composition of the invention for used for the production of allulose, in which the weight of each enzyme relative to the total weight of the enzymes (w/w)% is: 10-30% (aGP); 0-10% (4GT); 10-30%
(PGM); 0.1-10% (PGI); 01.-10% (P6PE); and (45-65%) P6PP, wherein the total weight of enzymes in the composition total 100 w/w% relative to the total weight of the enzymes. Some immobilized enzyme compositions of the invention for use in allulose production contain: 20% aGP; 3% 4GT; 165% PGM;
3% PGI; 3% P6PE; and P6PP 54%, wherein the % weight of each enzyme is relative to the total weight of the enzymes in the immobilized enzyme composition of the invention, and the total weight of enzymes in the composition is 100 w/w% relative to the total weight of the enzymes.
(PGI) and 0.1-10%
(4G1), when present. For example, an immobillized enzyme composition of the invention that can be used for the production of tagatose, the weight of each enzyme relative to the total weight of the enzymes (w/w)% is: 10-30% (aGP); 0-10% (4GT); 10-30% (PGM); 0.1-10% (PGI); 15-35% (F6PE); and T6PP
(25-45%), wherein the total weight of enzymes in the composition is 100 w/w%
relative to the total weight of the enzymes. Some immobilized enzyme compositions of the invention for use in tagatose production contain: 19% aGP; 3% 4GT; 17% PGM; 3% PGI; 23% F6PE; and T6PP 35%, wherein the % weight of each enzyme is relative to the total weight of the enzymes in the immobilized enzyme composition of the invention, and the total weight of enzymes in the composition is 100 w/w% relative to the total weight of the enzymes. In other examples, an immobillized enzyme composition of the invention for used for the production of allulose, in which the weight of each enzyme relative to the total weight of the enzymes (w/w)% is: 10-30% (aGP); 0-10% (4GT); 10-30%
(PGM); 0.1-10% (PGI); 01.-10% (P6PE); and (45-65%) P6PP, wherein the total weight of enzymes in the composition total 100 w/w% relative to the total weight of the enzymes. Some immobilized enzyme compositions of the invention for use in allulose production contain: 20% aGP; 3% 4GT; 165% PGM;
3% PGI; 3% P6PE; and P6PP 54%, wherein the % weight of each enzyme is relative to the total weight of the enzymes in the immobilized enzyme composition of the invention, and the total weight of enzymes in the composition is 100 w/w% relative to the total weight of the enzymes.
[0021] While enzymes contained in immobilized compositions of the invention are generally referred to based on the reactions they catalyze, (i.e., by specificity and function), enzymes are also commonly identified by amino acid sequence, (e.g., a SEQ. ID. NO.; a database indentification number, such as a UniProt ID), amino acid sequence identity/similarity to an enzyme of known function, nucleotide sequence, or nucleotide sequence identity/similarity to an enzyme of known function. Enzymes known in the art and used to prepare hexoses may be used in an immobilized enzyme composition of the invention, including immobilized enzyme compositions that can be used to produce , tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, and inositol. Exemplary enzymes known in the art may be used in a immoblized enzyme composition of the invention are identified below with a relevant patent document. The disclosure of the enzymes in the listed patents is specifically incorporated here by reference.
aGP PGM
PGI
Accordingly, in certain immobilized enzyme compositions, Table 1 provides a UniProt ID and SEQ. ID No.
to identify the amino acid sequences for the following non-limiting examples of enzymes that can be included in immobilized enzyme compositions of the invention: aGP, PGM, PGI, F6PE, T6PP, 4-GT, P6PE, and P6PP .
Table 1 Enzyme UniProt ID
(SEQ. ID. NO.) a glucan phosphorylase (aGP) G8NCCO
(SEQ. ID. NO. 1) Phosphoglucomutase (PGM) A0A0P6YKY9 (SEQ. ID. NO. 2) Phosphoglucoisomerase (1361) Q5SLL6 (SEQ. ID. NO. 3) fructose-6-phosphate epimerase (F6PE) A0A0P6XN50 (SEQ. ID. NO. 4) tagatose-6-phosphate phosphatase (T6PP) D1C7G9 (SEQ. ID. NO. 5) 1,4-glucan transferase (4-Cr) ERMXP8 (SEQ. ID. NO. 6) psicose 6-phosphate 3-epimerase (P6PE) A0A223HZ17 (SEQ. ID. NO. 7) psicose 6-phosphate phosphatase (P6PP) A0A0E3NCH4 (SEQ. ID. NO. 8)
aGP PGM
PGI
Accordingly, in certain immobilized enzyme compositions, Table 1 provides a UniProt ID and SEQ. ID No.
to identify the amino acid sequences for the following non-limiting examples of enzymes that can be included in immobilized enzyme compositions of the invention: aGP, PGM, PGI, F6PE, T6PP, 4-GT, P6PE, and P6PP .
Table 1 Enzyme UniProt ID
(SEQ. ID. NO.) a glucan phosphorylase (aGP) G8NCCO
(SEQ. ID. NO. 1) Phosphoglucomutase (PGM) A0A0P6YKY9 (SEQ. ID. NO. 2) Phosphoglucoisomerase (1361) Q5SLL6 (SEQ. ID. NO. 3) fructose-6-phosphate epimerase (F6PE) A0A0P6XN50 (SEQ. ID. NO. 4) tagatose-6-phosphate phosphatase (T6PP) D1C7G9 (SEQ. ID. NO. 5) 1,4-glucan transferase (4-Cr) ERMXP8 (SEQ. ID. NO. 6) psicose 6-phosphate 3-epimerase (P6PE) A0A223HZ17 (SEQ. ID. NO. 7) psicose 6-phosphate phosphatase (P6PP) A0A0E3NCH4 (SEQ. ID. NO. 8)
[0022] The amino acid sequences of enzymes contained in immobilized enzyme compositions of the invention also include enzymes, which may have been modified for any reason, such as, for example, to improve activity, stability (Le., half-life), or yield. Such modified enzymes include, for example, fragments of enzymes, amino acid substitutions, and chimeric proteins.
Modified enzymes includes variants of any enzyme disclosed herein. Variants may contain amino acid substitutions at one or more amino acid residues. A variant includes no more than 15, no more than 12, no more than 10, no more than 9, no more than 8, no more than 7, no more than 6, no more than 5, no more than 4, no more than 3, no more than 2 or no more than 1 conservative amino acid substitution relative to a naturally occurring enzyme and/or no more than 5, no more than 4, no more than 3, or no more than 2 non-conservative amino acid substitutions, or no more than 1 non-conservative amino acid substitution, relative to a naturally occurring enzymes. A conservative amino acid substitution is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art. These families include amino acids with basic side chains (e.g., lysine, arginine, histidine), acidic side chains (e.g., aspartic acid, glutamic acid), uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine), nonpolar side chains (e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), beta-branched side chains (e.g., threonine, valine, isoleucine) and aromatic side chains (e.g., tyrosine, phenylalanine, tryptophan). Variant enzymes of the invention may include amino acid substitutions with amino acid analogs as well as amino acids, as described herein.
Modified enzymes includes variants of any enzyme disclosed herein. Variants may contain amino acid substitutions at one or more amino acid residues. A variant includes no more than 15, no more than 12, no more than 10, no more than 9, no more than 8, no more than 7, no more than 6, no more than 5, no more than 4, no more than 3, no more than 2 or no more than 1 conservative amino acid substitution relative to a naturally occurring enzyme and/or no more than 5, no more than 4, no more than 3, or no more than 2 non-conservative amino acid substitutions, or no more than 1 non-conservative amino acid substitution, relative to a naturally occurring enzymes. A conservative amino acid substitution is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art. These families include amino acids with basic side chains (e.g., lysine, arginine, histidine), acidic side chains (e.g., aspartic acid, glutamic acid), uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine), nonpolar side chains (e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), beta-branched side chains (e.g., threonine, valine, isoleucine) and aromatic side chains (e.g., tyrosine, phenylalanine, tryptophan). Variant enzymes of the invention may include amino acid substitutions with amino acid analogs as well as amino acids, as described herein.
[0023] An enzyme contained in an enzyme composition of the invention can also be an enzyme, which: i) shares at least 35% sequence identity with the amino acid sequence of an enzyme disclosed herein; and ii) can catalyze the same reaction of that particular disclosed enzyme with the necessary specificity for the process. Accordingly, an enzyme in a composition of the invention includes enzymes with amino acid sequences that are at least 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47A, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89% 90% 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% sequence identity with the amino acid sequence of an enzyme disclosed herein. As used herein, the term "sequence identity" refers to the similarity between two, or more, amino acid or nucleic acid sequences.
Sequence identity is typically measured in terms of percentage identity (or similarity or homology) between amino acid sequences; the higher the percentage, the more similar to each other are the compared sequences.
Sequence identity is typically measured in terms of percentage identity (or similarity or homology) between amino acid sequences; the higher the percentage, the more similar to each other are the compared sequences.
[0024] As described above, enzyme compositions of the invention are immobilized to at least one carrier. A carrier may also be generally referred to herein as a "carrier material", "carrier resin", or a "carrier bead". In an immobilized enzyme composition of the invention, multiple different carriers may be used to immobilize one or more enzymes. While carriers in immobilized enzyme compositions of the invention are not necessarily limited to a particular material, in some immobilized enzyme compositions of the invention, the carrier is a weak base ion exchange resin, which may, optionally, be composed of phenol formaldehyde, (La, a phenol formaldehyde polycondensate). In yet other immobilized enzyme compositions of the invention, the carrier material is based on controlled pore glass (CPG) particles or hybrid CPG particles (W02015115993A1). The carriers in some immobilized enzyme compositions of the invention are functionalized by the inclusion of a tertiary amine group, while in others, a secondary amine group provides functionality. In some immobilized enzyme compositions of the invention, a carrier resin is functionalized with groups used to chelate a metal, such as, for example, iron or zinc.
The chelated metal groups allow high affinity binding of molecules via appropriate binding group, such as, for example, a Histidine (His)-tag. Examples of such functional groups are found in W02015115993A1 and Cassimjee et at A general protein purification and immobilization method on controlled porosity glass: biocatalytic applications. Chem. Commun., 2014, 50, 9134; including but not limiting to 2,4-dihydroxybenzyl residues.
The chelated metal groups allow high affinity binding of molecules via appropriate binding group, such as, for example, a Histidine (His)-tag. Examples of such functional groups are found in W02015115993A1 and Cassimjee et at A general protein purification and immobilization method on controlled porosity glass: biocatalytic applications. Chem. Commun., 2014, 50, 9134; including but not limiting to 2,4-dihydroxybenzyl residues.
[0025] The carriers in some immobilized enzyme compositions of the invention possess two or more of the various carrier features that are listed above. For example, in some immobilized enzyme compositions of the invention, the enzyme compositions of any of the immobilized enzyme compositions described, herein, for use in processes for converting starches and starch derivatives and saccharides to hexose monosaccharides, including processes for producing tagatose, psicose, fructose, allose, man nose, galactose, altrose, talose, sorbose, gulose, idose, or inositol, are immobilized to a weak base anion exchange resin; which may, or may not be composed of phenol formaldehyde polycondensate; and which may, or may not be functionalized by a tertiary amine group. A carrier resin with the foregoing features is sold commercially as DUOLITET" A568. In other immobilized enzyme compositions of the invention, the enzyme compositions of any of the immobilized enzyme compositions described, herein, for use in processes converting starches and starch derivatives and saccharides to hexose monosaccharides, including processes for producing tagatose, psicose, fructose, allose, man nose, galactose, altrose, talose, sorbose, gulose, idose, or inositol, are immobilized to a weak base anion exchange resin; which may, or may not be composed of phenol formaldehyde polycondensate; and which may, or may not be functionalized by a secondary amine group. A carrier resin with the foregoing features is sold commercially as DUOLITE PWA7. In yet other immobilized enzyme compositions of the invention, the enzyme compositions of any of the immobilized enzyme compositions described, herein, for use in processes converting starches and starch derivatives and saccharides to hexose monosaccharides, including processes for producing tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol, are immobilized to a His-tag affinity resin; which may, or may not be composed of a CPG or hybrid CPG
particle material carrier;
and which may, or may not chelate iron or zinc. A carrier resin with the foregoing features is sold commercially as EziGr" Opal.
particle material carrier;
and which may, or may not chelate iron or zinc. A carrier resin with the foregoing features is sold commercially as EziGr" Opal.
[0026] In general, the total weight of the enzymes in an immobilized enzyme composition of the invention, relative to the weight of the carrier (w/w)%, range from 2.5%-12.5%. Therefore, the total weight of the enzyme compositions of any of the immobilized enzyme compositions described, herein, for use in processes converting starches and starch derivatives and saccharides to hexose monosaccharides, including processes for producing tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol, relative to the weight of the carrier (w/w)%, can be about 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%, 6.5%, 10,4, 7.5%, 8%, 8.5%, 9%, 9.5%, 10%, 10.5%, 11%, 11.5%, 12%, 12.5%, or any w/w% therein. For example, the total weight of the enzymes, (aGP, PGM, PGI, F6PE, and T6PP) or (aGP, 46T, PGM, PGI, F6PE, and T6PP) in some immobilized enzyme compositions used to produce tagatose is 5%, while in the total weight of the enzymes (aGP, PGM, PGI, P6PE, and P6PP) or (aGP, 46T, PGM, PGI, P6PE, and P6PP) is 6.5%.
[0027] The invention also relates to an enzymatic process for preparing a hexose from a saccharide comprising the step of contacting a starch derivative with an immobilized enzyme composition of the invention under suitable reaction conditions to convert the starch derivative to the hexose. In an enzymatic processes of the invention for preparing a hexose, the at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight enzymes of a process may be immobilized on the same carrier, or immobilized on multiple carriers. For example, in an enzymatic process of the invention the enzymes may be immobilized on the same carrier, or the immobilized enzymes may be disributed among at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight carriers, which may be the same type of carrier, or any combination of different carriers and immobilization methodolgies, including weak base anion exchange resin carriers, phenol formaldehyde polycondensate carriers, carriers that a comprise tertiary amine functional group, (e.g., DUOLITET" A568), carriers that comprise a secondary amine functional groups, (e.g., DUOLITET" PWA7), carriers that comprise a His-tag affinity resin, carriers that comprise controlled pore glass (CPG) particles, and carriers functionalized by a chelated metal, including carriers in which the chelated metal is iron or zinc (e.g., EziGT" Opal).
[0028] Methods for immobilizing enzymes to any of the carriers described here, including appropriate buffer and reaction conditions for binding enzymes to carrier resins, are known in the art. See, for example, WO 2016/160573, which is incorporated here in its entirety
[0029] Processes for converting starches and starch derivatives and saccharides to hexoses using immobilized enzyme compositions of the invention can be performed under the same temperature, buffer, and reaction time paramenters used for the production of hexoses using non-immobilized enzymes in solution. For example, immobilized enzyme compositions of the invention can be used to produce tagatose, psicose, fructose, allose, mannose, galactose, altrose, talose, sorbose, gulose, idose, or inositol from starches and starch derivatives and saccharides under the reaction conditions described in published PCT applications WO 2018/169957, WO 2017/059278, and WO
2018/112139. The multiple catalyzation reaction steps in a process of producing a hexose using an immobilized enzyme composition of the invention can be conducted in a single bioreactor, or in a plurality of bioreactors that are arranged in series, or a reaction vessel. Alternatively, the steps can also be conducted in a plurality of bioreactors, or reaction vessels, that are arranged in series or parallel.
All aforementioned processes can be run in batch mode or continuous mode. A "one-pot" process in a single bioreactor is preferred.
2018/112139. The multiple catalyzation reaction steps in a process of producing a hexose using an immobilized enzyme composition of the invention can be conducted in a single bioreactor, or in a plurality of bioreactors that are arranged in series, or a reaction vessel. Alternatively, the steps can also be conducted in a plurality of bioreactors, or reaction vessels, that are arranged in series or parallel.
All aforementioned processes can be run in batch mode or continuous mode. A "one-pot" process in a single bioreactor is preferred.
[0030] The steps in an ezymatic processes of the invention can be conducted at a temperature ranging from about 35 C to about 90 C, about 40 C to about 70 C, about 50 C to about 60 C or about 55 C and at a pH ranging from about 5.0 to about an, about 65 to about 7.5 or about 7.0 to about 7.5.
They may be conducted for about 0.5 hours to about 48 hours, about 4 hours to 24 hours or about 8 hours to 12 hours. The enzymatic process steps of the inventions may be conducted ATP-free and/or NAD(P)(H)-free. The steps can be carried out at a phosphate concentration ranging from about 0.1 mM
to about 150 mM. The phosphate used in the phosphorylation and dephosphorylation steps of the processes according to the inventions can be recycled within the enzymatic cascade reaction. The processes of the invention can be carried out in a packed column or in a slurry.
They may be conducted for about 0.5 hours to about 48 hours, about 4 hours to 24 hours or about 8 hours to 12 hours. The enzymatic process steps of the inventions may be conducted ATP-free and/or NAD(P)(H)-free. The steps can be carried out at a phosphate concentration ranging from about 0.1 mM
to about 150 mM. The phosphate used in the phosphorylation and dephosphorylation steps of the processes according to the inventions can be recycled within the enzymatic cascade reaction. The processes of the invention can be carried out in a packed column or in a slurry.
[0031] For example, reaction phosphate concentrations in each of the processes can range from about 0.1 mM to about 300 mM, from about 0 mM to about 150 mM, from about 1 mM
to about 50 mM, preferably from about 5 mM to about 50 mM, or more preferably from about 10 mM to about 50 mM. For instance, the reaction phosphate concentration in each of the porcesses can be about 0.1 mM, about 0.5 mM, about 1 mM, about 1.5 mM, about 2 mM, about 2.5 mM, about 5 mM, about 6 mM, about 7 mM, about 8 mM, about 9 mM, about 10 mM, about 15 mM, about 20 mM, about 25 mM, about 30 mM, about 35 mM, about 40 mM, about 45 mM, about 50 mM, or about 55 mM.
to about 50 mM, preferably from about 5 mM to about 50 mM, or more preferably from about 10 mM to about 50 mM. For instance, the reaction phosphate concentration in each of the porcesses can be about 0.1 mM, about 0.5 mM, about 1 mM, about 1.5 mM, about 2 mM, about 2.5 mM, about 5 mM, about 6 mM, about 7 mM, about 8 mM, about 9 mM, about 10 mM, about 15 mM, about 20 mM, about 25 mM, about 30 mM, about 35 mM, about 40 mM, about 45 mM, about 50 mM, or about 55 mM.
[0032] Low phosphate concentration results in decreased production costs due to low total phosphate and thus lowered cost of phosphate removal. It also prevents inhibition of process enzymes by high concentrations of free phosphate and decreases the potential for phosphate pollution.
[0033] Furthermore, each of the processes disclosed herein can be conducted without added ATP as a source of phosphate, i.e., ATP-free. Each of the processes can also be conducted without having to add NAD(P)(H), i.e., NAD(P)(H)-free. Other advantages also include the fact that at least one step of the disclosed processes for making a hexose involves a highly energetically favorable chemical reaction which is essential for high yields. A highly energetically favorable chemical reaction for a process of the invention has an equilibrium constant (Keq) of at least 2, at least 3, or at least 4.
[0034] As a first step in a process of the invention, the starch derivatives can be prepared by enzymatic hydrolysis of starch or by acid hydrolysis of starch. See, for example, WO 2017/059278. For example, the enzymatic hydrolysis of starch can be catalyzed or enhanced by isoamylase (IA, EC.
3.2.1.68), which hydrolyzes a-1,6-glucosidic bonds; pullulanase (PA, EC.
3.2.1.41), which hydrolyzes a-1,6-glucosidic bonds; 4-a-glucanotransferase (4GT, EC. 2.4.1.25), which catalyzes the transglycosylation of short maltooligosaccharides, yielding longer maltooligosaccharides; or alpha-amylase (EC 3.2.1.1), which cleaves a-1,4-glucosidic bonds. Furthermore, derivatives of cellulose can be prepared by enzymatic hydrolysis of cellulose catalyzed by cellulase mixtures, by acids, or by pretreatment of biomass.
Examples
3.2.1.68), which hydrolyzes a-1,6-glucosidic bonds; pullulanase (PA, EC.
3.2.1.41), which hydrolyzes a-1,6-glucosidic bonds; 4-a-glucanotransferase (4GT, EC. 2.4.1.25), which catalyzes the transglycosylation of short maltooligosaccharides, yielding longer maltooligosaccharides; or alpha-amylase (EC 3.2.1.1), which cleaves a-1,4-glucosidic bonds. Furthermore, derivatives of cellulose can be prepared by enzymatic hydrolysis of cellulose catalyzed by cellulase mixtures, by acids, or by pretreatment of biomass.
Examples
[0035] Example 1. Evaluation of enzyme carriers. Enzyme carriers were evaluated for relative reaction rates of enzyme compositions for producing tagatose, as well as for their effect on enzyme stability. With those objectives in mind, the following enzyme carrier materials were evaluated: Four branded phenol-formaldehyde matrix resins (DUOLITE1" A568, DUOLITET" A561, DUOLITET" PWA7, AmberLite" FPA54); Two branded polystyrene resins (Lifetechn" ECR1640 and LifeTechT" ECR1504); Two branded polymethylacrylate resins (LifetechTM ECR8309M and ChromoliteTM
D6154); and a branded controlled pore glass resin (EziG Opal).
D6154); and a branded controlled pore glass resin (EziG Opal).
[0036] DUOLITET" A568 (DuPont) Ion Exchange Resin is a highly porous, granular, weak base anion exchange resin based on crosslinked phenol-formaldehyde polycondensate. Its hydrophilicity and controlled pore size distribution make it the most suitable resin to be used as an enzyme carrier in many bioprocessing applications. The ionic strength, pore volume, pore size, and particle size of DUOLITE"
A568 are designed for optimum immobilization of enzymes used in the starch and fat (and other) industries.
A568 are designed for optimum immobilization of enzymes used in the starch and fat (and other) industries.
[0037] DUOLITET" A561 Ion Exchange Resin is a weak basic anion exchanger made from phenol formaldehyde with a tertiary amine functional group, and its broad specifications are similar to DUOLITET" A568 resin, but DUOLITEw A561 has a different bead morphology.
[0038] DUOLITETs PWA7 is a weakly basic anion exchanger with amine functionality, and salt form.
[0039] AMBERLITE1" FPA54 Ion Exchange Resin is a highly porous, weak base, anion exchange resin, based on a crosslinked phenol-formaldehyde matrix. The low-swelling characteristics of AMBERLITET"
FPA54 give it excellent osmotic and physical stability resulting in less product loss and longer product life than conventional styrenic resins in food processing and bioprocessing applications. The hydrophilic phenolic, porous matrix of AMBERLITET" FPA54 permits the reversible adsorption of high molecular weight, organic, color bodies frequently found in solutions of natural product and fermentation products. AMBERLITErn FPA54 exhibits a high selectivity for sulfates and phosphates and, therefore, makes it ideal for the treatment of both citric and lactic acids derived from fermentation where it has a long history of use, particularly due to its excellent osmotic stability.
FPA54 give it excellent osmotic and physical stability resulting in less product loss and longer product life than conventional styrenic resins in food processing and bioprocessing applications. The hydrophilic phenolic, porous matrix of AMBERLITET" FPA54 permits the reversible adsorption of high molecular weight, organic, color bodies frequently found in solutions of natural product and fermentation products. AMBERLITErn FPA54 exhibits a high selectivity for sulfates and phosphates and, therefore, makes it ideal for the treatment of both citric and lactic acids derived from fermentation where it has a long history of use, particularly due to its excellent osmotic stability.
[0040] LifetechTM ECR1640 is a copolymer of divinylbenzene (DVB) and styerene functionalised with quaternary amines. It is used for enzyme immobilization by ionic interaction of the ionizable surface aminoacids (Lys, Arg, His, Asp, Glu) with the tertiary amines on the polymer.
It is particularly suitable for immobilization of enzymes with pls in the range 3-5 like many glycosidases. Lifetechna ECR1640 main features are the possibility to regenerate the resin, pH adjustment before immobilization and large particle size for column applications. DVB/styerene with quaternary amines, 300-1200 micron, pH
stability 1-14, supplied wet (66-72% water),capacity 0.85 eq/I Cl- form.
It is particularly suitable for immobilization of enzymes with pls in the range 3-5 like many glycosidases. Lifetechna ECR1640 main features are the possibility to regenerate the resin, pH adjustment before immobilization and large particle size for column applications. DVB/styerene with quaternary amines, 300-1200 micron, pH
stability 1-14, supplied wet (66-72% water),capacity 0.85 eq/I Cl- form.
[0041] Lifetech" ECR1504 is a copolymer of divinylbenzene (DVB) and styerene functionalised with tertiary amines. It is used for enzyme immobilization by ionic interaction of the ionizable surface a minoacids (Lys, Arg, His, Asp, Glu) with the tertiary amines on the polymer.
It is particularly suitable for immobilization of enzymes with pl in the range 3-5 like many glycosidaseses.
Lifetechm" ECR1504 main features are possibility to regenerate the resin, pH adjustment before immobilization and large particle size for column applications. DVB/styerene with tertiary amines, 300-1200 micron, pH stability 1-14, supplied wet (53-62% water),capacity 1.3 eq/I free base.
It is particularly suitable for immobilization of enzymes with pl in the range 3-5 like many glycosidaseses.
Lifetechm" ECR1504 main features are possibility to regenerate the resin, pH adjustment before immobilization and large particle size for column applications. DVB/styerene with tertiary amines, 300-1200 micron, pH stability 1-14, supplied wet (53-62% water),capacity 1.3 eq/I free base.
[0042] Lifetech" ECR8309M is a hydrophilic, high porosity, methacrylate polymer functionalized with amino groups on a short spacer (C2).
[0043] Chromolite" D6154 is macroporous polymethacrylate is a material, funtionalized for affinity binding specific for poly His-tags. The functional group is iminodiacetic, Na+
form
form
[0044] Ezir Opal is made from controlled pore glass (CPG) particles, and has a hydrophilic surface.
The material has a narrow pore size distribution, produced with a pore diameter of ¨500 A as standard.
A mass loading of 15- 60% active enzyme is expected. Other variations of EziG"
exist and were tested (Amber and Coral), but they performed suboptimally compared to Opal.
The material has a narrow pore size distribution, produced with a pore diameter of ¨500 A as standard.
A mass loading of 15- 60% active enzyme is expected. Other variations of EziG"
exist and were tested (Amber and Coral), but they performed suboptimally compared to Opal.
[0045] An enzyme composition containing the following weight/weight (w/w) percentages of each of the following enzymes, respectively, relative to to the total composition enzyme weight: 19% a-glucan phosphorylase (aGP, UNIPROT ID G8NCCO, SEQ. ID. NO. 1); 17% Phosphoglucomutase (PGM, UNIPROT
ID A0A0P6YKY9, SEQ. ID. NO. 2); 3% phosphoglucoisomerase (PGI, UNIPROT ID
05511_6, SEQ. ID. NO. 3);
23% fructose-6-phosphate epimerase (F6PE, UNIPROT ID A0A0P6XN50, SEQ. ID. NO.
4); 35% tagatose-6-phosphate phosphatase (T6PP, UNIPROT ID D1C769, SEQ. ID. NO. 5); and 3% 1,4-glucan transferase (4-GT, UNIPROT ID E8MXP8, SEQ. ID. NO. 6), was immobilized on to each of the carriers described above.
All immobilized enzyme preparations were 5% total enzyme weight/carrier. See Table 2. The foregoing enzyme ratios were previously optimized for tagatose production using the immobilization methodology described below.
ID A0A0P6YKY9, SEQ. ID. NO. 2); 3% phosphoglucoisomerase (PGI, UNIPROT ID
05511_6, SEQ. ID. NO. 3);
23% fructose-6-phosphate epimerase (F6PE, UNIPROT ID A0A0P6XN50, SEQ. ID. NO.
4); 35% tagatose-6-phosphate phosphatase (T6PP, UNIPROT ID D1C769, SEQ. ID. NO. 5); and 3% 1,4-glucan transferase (4-GT, UNIPROT ID E8MXP8, SEQ. ID. NO. 6), was immobilized on to each of the carriers described above.
All immobilized enzyme preparations were 5% total enzyme weight/carrier. See Table 2. The foregoing enzyme ratios were previously optimized for tagatose production using the immobilization methodology described below.
[0046] Table 2 % of enzyme Enzyme Uniprot ID
composition a glucan phosphorylase (aGP) G8NCCO
(SEQ. ID. NO. 1) 19%
Phosphoglucomutase (PGM) A0A0P6YKY9 (SEQ. ID. NO. 2) 17%
Phosphoglucoisomerase (PGI) Q55L16 (SEQ. ID. NO. 3) 3%
fructose-6-phosphate epimerase (F6PE) A0A0P6XN50 (SEQ. ID. NO.4) 23%
tagatose-6-phosphate phosphatase (T6PP) D1C769 (SEQ. ID. NO. 5) 35%
1,4-glucan transferase (4-GT) E8MXP8 (SEQ. ID. NO. 6) 3%
composition a glucan phosphorylase (aGP) G8NCCO
(SEQ. ID. NO. 1) 19%
Phosphoglucomutase (PGM) A0A0P6YKY9 (SEQ. ID. NO. 2) 17%
Phosphoglucoisomerase (PGI) Q55L16 (SEQ. ID. NO. 3) 3%
fructose-6-phosphate epimerase (F6PE) A0A0P6XN50 (SEQ. ID. NO.4) 23%
tagatose-6-phosphate phosphatase (T6PP) D1C769 (SEQ. ID. NO. 5) 35%
1,4-glucan transferase (4-GT) E8MXP8 (SEQ. ID. NO. 6) 3%
[0047] Prior to adhering the enzymes in the composition to each carrier, the carrier was equilibrated with two equivalent volumes of water, and then three equivalent volumes of immobilization buffer pH
7.2 (5 mM Na2PO4, 5 mM MgSO4, 0.25 mM MnCl2). The enzymes were suspended in the immobilization buffer to form the enzyme composition (preferably between 5 and 10 g/L enzyme) which was then added to the carrier to make a slurry. During room temperature incubation on an orbital shaker at 800 rpm, the absorbance of the enzyme composition and carrier slurry was measured at 280 nm to track the adsorbtion of the enzymes to the carrier until >95% of the soluble enzymes were no longer suspended in solution, which was around 6 hrs for a 5% (w/w, enzymes/carrier) loaded sample. The supernatant was removed and immobilized carrier washed with reaction buffer pH 7.2 (25 mM
Na2PO4, 4 mM
Na2S03, 2.5 mM MgSO4, 0.25 mM MnCl2) to remove any remaining soluble enzymes.
Each slurry sample was mixed with an equal volume of a 2X concentrated feed solution (320 g/L
maltodextrin dextrose equivalent S (DES) pH 7.2, 25 mM Na2PO4, 4 mM Na2S03, 2.5 mM MgSO4, 0.25 mM
MnCl2) to achieve a final maltodextrin substrate concentration of 160 g/L in reaction conditions.
The maltodextrin ¨ carrier mixture was shaken overnight in a 2.0 mL microfuge tube in an Eppendorf Thermomixer F2.0 at 800-1500 rpm, and at either 50 C for the DUOLITET" A568, Lifetechl" ECR1640, LifeTechT" ECR1504, Lifetechlm ECR8309M, ChromoliteTM D6154, and EziGTh" Opal composition-carrier combinations 55 C for the DUOLITET" A561, DUOLITET" PWA7, AmberLitr FPA54 composition-carrier combinations. The reaction continued for 15-18 hours. The resulting product was developed on a HiPlex H Ligand Exchange column (Agilent) using an Agilent 1100 series HPLC system with in-line refractive index detector (0.6 mL/min with 5 mM H2504 mobile phase at 65 C). Tagatose concentration was determined by comparing sample peak areas to those of known tagatose standard solutions.
Immobilized enzyme composition cascade activity rates (Rmol of tagatose produced/min/mg of total enzyme) were calculated for each carrier. Cascade activity rates for each carrier-composition preparation are reported in Table 1 relative to the cascade activity rate of the Duolite A568 carrier-composition preparation.
Remaining maltodextrin and tagatose were washed off each immobilized enzyme preparation by five washes, each consisting of at least three volume equivalents of reaction buffer to equilibrate the preparation for re-use. The immobilized enzyme preparations were re-used by adding 2X concentrated maltodextrin feed solution as before. Reaction rates were calculated with each subsequent use and plotted to ascertain the working half-life of the immobilized catalyst. The half-life was determined by measuring the cascade rate ( mol/min/mg) on Day 0 and subsequent days until less than half the activity was lost consistently (compared to Day 0). A designation of n/d in Table 3 indicates <10% of the half-life was found or the cascade activity was <50% of Duolite A568.
7.2 (5 mM Na2PO4, 5 mM MgSO4, 0.25 mM MnCl2). The enzymes were suspended in the immobilization buffer to form the enzyme composition (preferably between 5 and 10 g/L enzyme) which was then added to the carrier to make a slurry. During room temperature incubation on an orbital shaker at 800 rpm, the absorbance of the enzyme composition and carrier slurry was measured at 280 nm to track the adsorbtion of the enzymes to the carrier until >95% of the soluble enzymes were no longer suspended in solution, which was around 6 hrs for a 5% (w/w, enzymes/carrier) loaded sample. The supernatant was removed and immobilized carrier washed with reaction buffer pH 7.2 (25 mM
Na2PO4, 4 mM
Na2S03, 2.5 mM MgSO4, 0.25 mM MnCl2) to remove any remaining soluble enzymes.
Each slurry sample was mixed with an equal volume of a 2X concentrated feed solution (320 g/L
maltodextrin dextrose equivalent S (DES) pH 7.2, 25 mM Na2PO4, 4 mM Na2S03, 2.5 mM MgSO4, 0.25 mM
MnCl2) to achieve a final maltodextrin substrate concentration of 160 g/L in reaction conditions.
The maltodextrin ¨ carrier mixture was shaken overnight in a 2.0 mL microfuge tube in an Eppendorf Thermomixer F2.0 at 800-1500 rpm, and at either 50 C for the DUOLITET" A568, Lifetechl" ECR1640, LifeTechT" ECR1504, Lifetechlm ECR8309M, ChromoliteTM D6154, and EziGTh" Opal composition-carrier combinations 55 C for the DUOLITET" A561, DUOLITET" PWA7, AmberLitr FPA54 composition-carrier combinations. The reaction continued for 15-18 hours. The resulting product was developed on a HiPlex H Ligand Exchange column (Agilent) using an Agilent 1100 series HPLC system with in-line refractive index detector (0.6 mL/min with 5 mM H2504 mobile phase at 65 C). Tagatose concentration was determined by comparing sample peak areas to those of known tagatose standard solutions.
Immobilized enzyme composition cascade activity rates (Rmol of tagatose produced/min/mg of total enzyme) were calculated for each carrier. Cascade activity rates for each carrier-composition preparation are reported in Table 1 relative to the cascade activity rate of the Duolite A568 carrier-composition preparation.
Remaining maltodextrin and tagatose were washed off each immobilized enzyme preparation by five washes, each consisting of at least three volume equivalents of reaction buffer to equilibrate the preparation for re-use. The immobilized enzyme preparations were re-used by adding 2X concentrated maltodextrin feed solution as before. Reaction rates were calculated with each subsequent use and plotted to ascertain the working half-life of the immobilized catalyst. The half-life was determined by measuring the cascade rate ( mol/min/mg) on Day 0 and subsequent days until less than half the activity was lost consistently (compared to Day 0). A designation of n/d in Table 3 indicates <10% of the half-life was found or the cascade activity was <50% of Duolite A568.
[0048] Table 3 Carrier Name Material Enzyme Cascade Activity Half-life (%
Immobilization Rate (% relative to relative to Interaction DUOUTET" A568) DUOLITET"
with Carrier A568) DUOLITET" A568 phenol- Ionic 100.0% 100%
formaldehyde DUOLITET" A561 phenol- Ionic 41.3%* n/d formaldehyde DUOLITET" PWA7 phenol- Ionic 92.0%* 100%
formaldehyde AMBERLITETh' FPA54 phenol- Ionic 25.7%* n/d formaldehyde LifetechTh ECR1640 polystyrene Ionic 35.9% n/d LifeTechT" ECR1 polystyrene Ionic 2.2% n/d LifetechT" ECR8309IVI polymethacrylate Ionic 77.5% 10%
Chromolitew D6154 polymethacrylate Affinity 59.4% 10%
EziGT" Opal controlled pore Affinity 119.6% 30%
glass * saccharide to hexose reaction performed at 55 C
Immobilization Rate (% relative to relative to Interaction DUOUTET" A568) DUOLITET"
with Carrier A568) DUOLITET" A568 phenol- Ionic 100.0% 100%
formaldehyde DUOLITET" A561 phenol- Ionic 41.3%* n/d formaldehyde DUOLITET" PWA7 phenol- Ionic 92.0%* 100%
formaldehyde AMBERLITETh' FPA54 phenol- Ionic 25.7%* n/d formaldehyde LifetechTh ECR1640 polystyrene Ionic 35.9% n/d LifeTechT" ECR1 polystyrene Ionic 2.2% n/d LifetechT" ECR8309IVI polymethacrylate Ionic 77.5% 10%
Chromolitew D6154 polymethacrylate Affinity 59.4% 10%
EziGT" Opal controlled pore Affinity 119.6% 30%
glass * saccharide to hexose reaction performed at 55 C
[0049] Example 2. Effect of enzyme ratio on cascade rate. To evaluate the effect of changing the ratios of various immobilized enzymes on tagatose production, the amounts of aGP, PGM, PGI, F6PE, T6PP, and 4-GT immobilized on DUOLITET" A568 were varied relative to the DUOLITET" A568-immobilized composition that was prepared using the enzyme ratios described in Example land Table 1 ("the Example 1 immobilized composition"), in two, immobilized composition preparations. Their activity rates were evaluated against the performance of the Example 1 immobilized composition. In one of the varied-concentration immobilized compositions, the amounts of the enzymes were based on the observed rate of each enzyme relative to T6PP in solution, as shown in Table 4 (Fig. 1B), where an equal amount of enzyme activity (prnol/min) was added for each enzyme. The activity rate of this immobilized composition was 74% of the optimal ratio. The other varied-concentration immobilized composition contained equal amounts of each enzyme by weight (Fig. 1C). The activity rate of this immobilized composition was 85% of the optimal ratio. Reactions were carried out and conversion rates measured in p.mol/min/mg total enzymes as described in Example 1.
Table 4 Enzyme activity as % of Enzyme T6PP activity a glucan phosphorylase (aGP) 78%
Phosphoglucomutase (PGM) 861%
Phosphoglucoisomerase (PGI) 2930%
fructose-6-phosphate epimerase (F6PE) 215%
tagatose-6-phosphate phosphatase (T6PP) 100%
1,4-glucan transferase (4-GT) 977%
Table 4 Enzyme activity as % of Enzyme T6PP activity a glucan phosphorylase (aGP) 78%
Phosphoglucomutase (PGM) 861%
Phosphoglucoisomerase (PGI) 2930%
fructose-6-phosphate epimerase (F6PE) 215%
tagatose-6-phosphate phosphatase (T6PP) 100%
1,4-glucan transferase (4-GT) 977%
[0050] Example 3: Effect of distribution of enzymes on one or more carriers.
The process of producing tagatose from maltodextrin using a DUOLITET" A568-immobilized composition prepared in a single immobilization reaction as described in Example 1 (19% aGP, 17% PGM, 3%
PGI, 23% F6PE, 35%
T6PP, and 3% 4-GT), was compared to activity rates of processes performed using: (1) A mixture of a DUOLITET" A568-immobilized composition of the core production enzymes (aGP, PGM, PGI, and 46T) and a DUOLITET" A568-immobilized composition of the tagatose production-specific enzymes (F6PE and T6PP); and (2) A mixture of 6, separate, immobilized enzyme preparations:
DUOLITET" A568 immobilized aGP, DUOLITEna A568-immobilized PGM, DUOLITET'a A568-immobilized PGI, DUOLITE"" A568-immobilized 4GT, DUOLITElm A568-immobilized F6PE and DUOUTET" A568-immobilized T6PP. All the enzymes in (1) and (2) were present in the same ratios as in the referenced DUOUTErm A568-immobilized composition, and all immobilizations were performed using a 5% w/w ratio (enzyme/carrier), and buffers/reaction conditions as described in Example 1.
The results are shown in Table 5.
Table 5 Co-immobilization configuration Relative activity rate a.GP + PGM + P61 + 46T + F6PE + 46T immobilized composition 100%
Combination of aGP + PGM + PGI + 4GT immobilized composition 85.1%
and F6PE + T6PP immobilized composition Combination of separately immobilized aGP + PGM + PGI + 4GT +
27.2%
F6PE + 4GT + F6PE + T6PP
The process of producing tagatose from maltodextrin using a DUOLITET" A568-immobilized composition prepared in a single immobilization reaction as described in Example 1 (19% aGP, 17% PGM, 3%
PGI, 23% F6PE, 35%
T6PP, and 3% 4-GT), was compared to activity rates of processes performed using: (1) A mixture of a DUOLITET" A568-immobilized composition of the core production enzymes (aGP, PGM, PGI, and 46T) and a DUOLITET" A568-immobilized composition of the tagatose production-specific enzymes (F6PE and T6PP); and (2) A mixture of 6, separate, immobilized enzyme preparations:
DUOLITET" A568 immobilized aGP, DUOLITEna A568-immobilized PGM, DUOLITET'a A568-immobilized PGI, DUOLITE"" A568-immobilized 4GT, DUOLITElm A568-immobilized F6PE and DUOUTET" A568-immobilized T6PP. All the enzymes in (1) and (2) were present in the same ratios as in the referenced DUOUTErm A568-immobilized composition, and all immobilizations were performed using a 5% w/w ratio (enzyme/carrier), and buffers/reaction conditions as described in Example 1.
The results are shown in Table 5.
Table 5 Co-immobilization configuration Relative activity rate a.GP + PGM + P61 + 46T + F6PE + 46T immobilized composition 100%
Combination of aGP + PGM + PGI + 4GT immobilized composition 85.1%
and F6PE + T6PP immobilized composition Combination of separately immobilized aGP + PGM + PGI + 4GT +
27.2%
F6PE + 4GT + F6PE + T6PP
[0051] Example 4. Effect of enzyme loading. Enzymes at different loadings (g enzymes / g carrier ranging from 23% to 12.5% in 2.5% intervals) were immobilized on Duolite A568 as described in Example 1 and in the ratios listed in Table 2. Unlike Example 1, however, the immobilizations were allowed to continue for 16 hrs for each sample instead of 6 hrs to allow time for binding of enzymes to reach completion for the higher loadings. Soluble enzymes were washed off with five washes containing at least three sample volumes of reaction buffer pH 7.2 (25 mM Na2PO4, 4 mM
Na2S03, 2.5 mM MgSO4, 0.25 mM MnCl2). The samples were reacted with maltodextrin feed solution for 16 hours and conversion rates measured in pLmol/min/mg total enzymes as in Example 1. The relative enzymatic cascade rates with respect to a 5% loaded sample are plotted as a function of loading in Figure 2. The loading response together with the price of enzymes and support allows design of the most cost efficient catalyst.
Na2S03, 2.5 mM MgSO4, 0.25 mM MnCl2). The samples were reacted with maltodextrin feed solution for 16 hours and conversion rates measured in pLmol/min/mg total enzymes as in Example 1. The relative enzymatic cascade rates with respect to a 5% loaded sample are plotted as a function of loading in Figure 2. The loading response together with the price of enzymes and support allows design of the most cost efficient catalyst.
[0052] Example 5. Allulose preparation using an immobilized enzyme composition. Enzyme compositions containing the following enzymes, aGP, PGM, P61, psicose 6-phosphate 3-epimerase (P6PE), psicose 6-phosphate phosphatase (P6PP), and 4-61 in three different ratios among the enzymes were immoblized to DUOLITE" A568 in respective immobilization reactions, as described in Table 6. A
comparative analysis of the three immobilized composition preparations to produce allulose from maltodextrin was performed.
Table 6. Enzyme composition of allulose immobilization % w/w (enzyme/composition) Enzyme Uniprot ID
Prep 1 Prep 2 Prep 3 a glucan phosphorylase (aGP) G8NCCO (SEQ. ID. NO.
1) 20% 20% 20%
Phosphoglucomutase (PGM) A0A0P6YKY9 (SEQ. ID.
NO. 2) 16.5% 16.5% 16.5%
Phosphoglucoisomerase (PGI) Q5SLL6 (SEQ. ID. NO.
3) 3% 3% 3%
psicose 6-phosphate 3-epimerase 3% 7% 14%
A0A223HZ17 (SEQ. ID. NO. 7) (P6PE) psicose 6-phosphate 54% 5036 43%
A0A0E3NCH4 (SEQ. ID. NO. 8) phosphatase (P6PP) 1,4-glucan transferase (4-GT) D7BF07 (SEQ. ID. NO.
6) 3% 3% 3%
comparative analysis of the three immobilized composition preparations to produce allulose from maltodextrin was performed.
Table 6. Enzyme composition of allulose immobilization % w/w (enzyme/composition) Enzyme Uniprot ID
Prep 1 Prep 2 Prep 3 a glucan phosphorylase (aGP) G8NCCO (SEQ. ID. NO.
1) 20% 20% 20%
Phosphoglucomutase (PGM) A0A0P6YKY9 (SEQ. ID.
NO. 2) 16.5% 16.5% 16.5%
Phosphoglucoisomerase (PGI) Q5SLL6 (SEQ. ID. NO.
3) 3% 3% 3%
psicose 6-phosphate 3-epimerase 3% 7% 14%
A0A223HZ17 (SEQ. ID. NO. 7) (P6PE) psicose 6-phosphate 54% 5036 43%
A0A0E3NCH4 (SEQ. ID. NO. 8) phosphatase (P6PP) 1,4-glucan transferase (4-GT) D7BF07 (SEQ. ID. NO.
6) 3% 3% 3%
[0053] To prepare the immobilized cocktails, DUOLITET" A568 was pretreated a 1% aqueous solution of glutaraldehyde (GA) for 2 hours at room temperature in an end-over-end rotator. The GA was removed by washing 5x with water and 2x conditioning washes with immobilization buffer (10 mM
sodium phosphate buffer pH 7.2, 5 mM MgSO4, and 80 MM CoCl2). Enzyme solutions (Table 5) were then added to the GA-pretreated carrier after the final wash step (supernatant discarded). The enzyme solutions consisted of 5 g/L enzyme in reaction buffer (10 mM sodium phosphate buffer pH 7.2,5 mM
MgSO4, 5 mM NaS03, and 80 p.M CoCl2). The enzyme plus carrier solutions were incubated at room temperature for 16 hours on an orbital shaker set at 800 rpm to immobilize the enzyme mixtures in the carrier. The total percent loading was 6.5% (mg of enzyme per mg of carrier).
The supernatant was washed off with six washes consisting of reaction buffer to remove any remaining non-bound enzymes.
The final supernatant was removed and 150 g/L maltodextrin, previously dissolved in reaction buffer was added. The maltodextrin ¨ carrier mixture was shaken overnight (15-16 hours) in a 2.0 mL
microfuge tube in an Eppendorf Thermomixer F2.0 at 800 - 1500 rpm and 55 C.
The resulting product was developed on a SupelCogel Pb column (Sigma Aldrich) using an Agilent 1100 series HPLC system with in-line refractive index detector (0.6 mlimin with ultrapure water mobile phase at 80 C). Allulose concentrations were determined by comparing sample peak areas to those of known allulose standard solutions, and enzymatic cascade specific activity rates calculated. The allulose production reaction was washed off each immobilization preparation with 4x washes of reaction buffer to equilibrate the immobilized preparation for re-use. The results of each sample composition's relative specific activities are shown below in Table 7.
Table 7. Relative activities of immobilized allulose production enzymes Immobilized Allulose Relative Specific Activity Compositions (ptmol/min/mg of enzyme) Prep 1 100%
Prep 2 77.7%
51.1%
Prep 3
sodium phosphate buffer pH 7.2, 5 mM MgSO4, and 80 MM CoCl2). Enzyme solutions (Table 5) were then added to the GA-pretreated carrier after the final wash step (supernatant discarded). The enzyme solutions consisted of 5 g/L enzyme in reaction buffer (10 mM sodium phosphate buffer pH 7.2,5 mM
MgSO4, 5 mM NaS03, and 80 p.M CoCl2). The enzyme plus carrier solutions were incubated at room temperature for 16 hours on an orbital shaker set at 800 rpm to immobilize the enzyme mixtures in the carrier. The total percent loading was 6.5% (mg of enzyme per mg of carrier).
The supernatant was washed off with six washes consisting of reaction buffer to remove any remaining non-bound enzymes.
The final supernatant was removed and 150 g/L maltodextrin, previously dissolved in reaction buffer was added. The maltodextrin ¨ carrier mixture was shaken overnight (15-16 hours) in a 2.0 mL
microfuge tube in an Eppendorf Thermomixer F2.0 at 800 - 1500 rpm and 55 C.
The resulting product was developed on a SupelCogel Pb column (Sigma Aldrich) using an Agilent 1100 series HPLC system with in-line refractive index detector (0.6 mlimin with ultrapure water mobile phase at 80 C). Allulose concentrations were determined by comparing sample peak areas to those of known allulose standard solutions, and enzymatic cascade specific activity rates calculated. The allulose production reaction was washed off each immobilization preparation with 4x washes of reaction buffer to equilibrate the immobilized preparation for re-use. The results of each sample composition's relative specific activities are shown below in Table 7.
Table 7. Relative activities of immobilized allulose production enzymes Immobilized Allulose Relative Specific Activity Compositions (ptmol/min/mg of enzyme) Prep 1 100%
Prep 2 77.7%
51.1%
Prep 3
[0054] Example 6. Allose preparation from maltodextrin using an immobilized enzyme composition.
Allose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, 4GT and P6PE, A6PI, and A6PP.
Allose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, 4GT and P6PE, A6PI, and A6PP.
[0055] Example 7. Fructose preparation from maltodextrin using an immobilized enzyme composition. Fructose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, 46T, and F6PP.
[0056] Example 8. Mannose preparation from maltodextrin using an immobilized enzyme composition. Fructose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, 4GT, and M6PI or PGPMI and M6PP.
[0057] Example 9. Galactose preparation from maltodextrin using an immobilized enzyme composition. Galactose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, 46T, Gal6PI and Gal6P.
[0058] Example 10. Altrose preparation from maltodextrin using an immobilized enzyme composition.
Altrose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, P6PE, Alt6PI, and Alt6PP.
Altrose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, P6PE, Alt6PI, and Alt6PP.
[0059] Example 11. Talose preparation from maltodextrin using an immobilized enzyme composition.
Talose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, Tal6PI, and Tal6PP.
Talose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, Tal6PI, and Tal6PP.
[0060] Example 12. Sorbose preparation from maltodextrin using an immobilized enzyme composition. Sorbose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, S6PE, and S6PP.
[0061] Example 13. Gulose preparation from maltodextrin using an immobilized enzyme composition.
Gulose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, 56PE, Gul6PI, and Gul6PP.
Gulose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, 56PE, Gul6PI, and Gul6PP.
[0062] Example 15. (dose preparation from maltodextrin using an immobilized enzyme composition.
Idose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, S6PE,I6P1, and I6PP.
Idose will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, PGI, F6PE, S6PE,I6P1, and I6PP.
[0063] Example 16. trios/to) preparation from maltodextrin using an immobilized enzyme composition. Inositol will be produced from maltodextrin using an immobilized enzyme composition that includes aGP, PGM, 4GT, IPS, and IMP.
Claims (22)
- What is claimed:
L An immobilized enzyme composition for the preparation of a hexose comprising at least two, at least three, at least four, at least five, at least six carriers, at least seven, or at least eight of the following enzymes immobilized to at least one carrier or a mixture of carriers:
a) a glucan phosphorylase (aGP), phosphoglucomutase (PGM), and optionally 14-glucan transferase (4-GT); and b) an enzyme from within a cornbination of enzymes selected from:
(i) phosphoglucoisomerase (PGI), fructose-6-phosphate epimerase (F6PE), and tagatose-6-phosphate phosphatase (T6PP) to prepare tagatose;
(ii) phosphoglucoisomerase (PGI), pi5c0se-6-phosphate epimerase (P6PE), and picose-6-phosphate phosphatase (P6PP) to prepare allulose;
(iii) phosphoglucoisomerase (PGI), P6PE, allose-6-phosphate isomerase (A6PI), and allose-6-phosphate phosphatase (A6PP) to prepare allose;
(iv) phosphoglucoisomerase (PGI), mannose-6-phosphate isomerase (M6P1) or phosphoglucose/phosphomannose isomerase (PGPMI), and mannose 6-phosphate phosphatase (M6PP) to prepare mannose;
(v) phosphoglucoisomerase (PGI), F6PE, galactose 6-phosphate isomerase (Gal6P1), and galactose 6-phosphate phosphatase (6al6PP) to prepare galactose;
(vi) PGI and fructose 6-phosphate phosphatase (F6PP) to prepare fructose;
(vii) PGI, P6PE, altrose 6-phosphate isomerase (Alt6P1), and altrose 6-phosphate phosphatase (Alt6PP) to prepare altrose;
(viii) PGI, F6PE, talose 6-phosphate isomerase (Tal6P1), and talose 6-phosphate phosphatase (Tal6PP) to prepare talose;
(ix) PGI, F6PE, sorbose 6-phosphate epimerase (S6PE), and sorbose 6-phosphate phosphatase (S6PP) to prepare sorbose;
(x) PGI, F6PE, S6PE, gulose 6-phosphate isomerase (Gul6P1), and gulose 6-phosphate phosphatase (Gul6PP) to prepare gulose;
(xi) PGI, F6PE, S6PE, idose 6-phosphate isomerase (16PI), and idose 6-phosphate phosphatase (I6PP) to prepare idose; and (xii) inositol 3-phosphate synthase (IPS) and inositol monophosphatase (IMP) to prepare inositol. - 2. The immobilized enzyme composition of claim 1, wherein the weight of each enzyme relative to the total weight of the enzyrnes (w/w)% ranges from 0.1% to 40%.
- 3. The immobilized enzyrne composition of claim 1 or 2, comprising 10-30%
(aGP); 0-10% (4GT); 10-30% (PGM); and when present 0.1-10% (PGI). - 4. The immobilized enzyrne composition of any one of claim 3, further comprising PGI, F6PE, and T6PP to prepare tagatose.
- 5. The immobilized enzyme composition of claim 4, wherein the weight of each enzyme relative to the total weight of the enzymes (w/w)% is: 10-30% (aGP); 0-10% (4GT); 10-30%
(PGM); 0.1-10% (PGI);
15-35% (F6PE); and T6PP (25-45%), wherein the total weight of enzymes in the composition total 100 w/w% relative to the total weight of the enzymes. - 6. The immobilized enzyme composition of claim 5, wherein the aGP comprises the amino acid sequence, or fragment thereof, of SEQ ID NO.
1;
the 4-GT comprises the amino acid sequence, or fragment thereof, of SEQ ID NO.
6;
the PGM comprises the amino acid sequence, or fragment thereof, of SEQ ID NO.
2;
the PGI comprises the amino acid sequence, or fragment thereof, of SEQ ID NO.
the F6PE comprises the amino acid sequence, or fragment thereof, of SEQ ID NO.
4; and the T6PP comprises the amino acid sequence, or fragment thereof, of SEQ ID NO.
5. - 7. The immobilized enzyme composition of any one of claim 3, further comprising PGI, P6PE, and P6PP to prepare allulose.
- 8. The immobilized enzyrne composition of claim 7, wherein the weight of each enzyme relative to the total weight of the enzymes (w/w)% is: 10-30% (aGP); 0-10% (467); 10-30%
(PGM); 0.1-10% (PGI);
0.1-10% (P6PE); and (45-65%) P6PP, wherein the total weight of enzymes in the composition total 100 w/w% relative to the total weight of the enzymes. - 9. The immobilized enzyrne composition of claim 8, wherein:
the aGP comprises the amino acid sequence, or fragment thereof, of SEQ ID NO.
1;
the 4-GT comprises the amino acid sequence of SEQ ID NO. 6;
the PGM comprises the amino acid sequence of SEQ ID NO. 2;
the PGI comprises the amino acid sequence of SEQ ID NO. 3 the P6PE comprises the amino acid sequence of SEQ ID NO. 7; and the P6PP comprises the amino acid sequence of SEQ ID NO. 8. - 10. The immobilized enzyme composition of any one of claims 1-9, wherein the total weight of the enzymes relative to the weight of the carrier (w/w)% is from 2.5%-12.5%.
- 11. The immobilized enzyme composition of any one of claims 1-10, wherein the carrier is a weak base anion exchange resin.
- 12. The immobilized enzyme composition of claim 11, wherein the carrier comprises a phenol formaldehyde polycondensate.
- 13. The immobilized enzyrne composition of claim 11 or 12, wherein the carrier comprises a tertiary amine functional group, wherein the composition is, optionally, DUOLITET"
A568. - 14. The immobilized enzyme composition of claim 11 or 12, wherein the carrier comprises a secondary amine functional group, wherein the composition is, optionally, DUOUTET" PWA7.
- 15. The immobilized enzyme composition of any one of claims 1-10, wherein the carrier comprises a His-tag affinity resin.
- 16. The immobilized enzyme composition of any one of claims 15, wherein the carrier comprises controlled pore glass (CPG) particles.
- 17. The immobilized enzyrne composition of claim 15 or 16, wherein the carrier is functionalized by a chelated metal.
- 18. The immobilized enzyme composition of claim 18, wherein the chelated metal is iron or zinc or wherein the carrier is, optionally, EziGl" Opal.
- 19. An enzymatic process for preparing a hexose from a saccharide comprising the step of contacting a starch derivative with an immobilized enzyme composition of any one of claims 1-18 under suitable reaction conditions convert the starch derivative to the hexose.
- 20. The process of claim 19, wherein the process steps are conducted at a temperature ranging from about 40 C to about 85nC, at a pH ranging from about 5.0 to about 8.0, and/or for about 0.5 hours to about 48 hours.
- 21. The process of claim 19 or 20, wherein the process steps are conducted in a single bioreactor, a plurality of bioreactors arranged in series, or a plurality of bioreactors arranged in parallel.
- 22. The process of any one of claims 19-21, wherein the process steps are conducted ATP-free, NAD(P)(H)-free, at a phosphate concentration from about 0.1 mM to about 150 mM, the phosphate is recycled within the enzymatic cascade reaction, and/or at least one step of the process involves a highly energetically favorable chemical reaction.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962875321P | 2019-07-17 | 2019-07-17 | |
US62/875,231 | 2019-07-17 | ||
US201962924323P | 2019-10-22 | 2019-10-22 | |
US62/924,323 | 2019-10-22 | ||
PCT/US2020/042562 WO2021011881A1 (en) | 2019-07-17 | 2020-07-17 | Immobilized enzyme compositions for the production of hexoses |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3143852A1 true CA3143852A1 (en) | 2021-01-21 |
Family
ID=74209943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3143852A Pending CA3143852A1 (en) | 2019-07-17 | 2020-07-17 | Immobilized enzyme compositions for the production of hexoses |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3999636A4 (en) |
JP (1) | JP2022541471A (en) |
KR (1) | KR20220035460A (en) |
CN (1) | CN114599786A (en) |
BR (1) | BR112022000699A2 (en) |
CA (1) | CA3143852A1 (en) |
CO (1) | CO2022001348A2 (en) |
MX (1) | MX2022000381A (en) |
WO (1) | WO2021011881A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2023008520A (en) * | 2021-02-02 | 2023-09-25 | Bonumose Inc | Enzymatic enrichment of food ingredients for sugar reduction. |
CN112708614A (en) * | 2021-02-05 | 2021-04-27 | 江南大学 | Preparation method and application of co-immobilized double enzymes |
CN112760317B (en) * | 2021-04-07 | 2021-08-24 | 中国科学院天津工业生物技术研究所 | Method for producing tagatose by biomimetic silicified microcapsule immobilized multienzyme |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4778418B2 (en) * | 2003-03-06 | 2011-09-21 | ヴェレニウム コーポレイション | Amylase, nucleic acid encoding the same, and production and use thereof |
US20080148432A1 (en) * | 2005-12-21 | 2008-06-19 | Mark Scott Abad | Transgenic plants with enhanced agronomic traits |
CA2599577A1 (en) * | 2005-03-04 | 2006-09-14 | Verenium Corporation | Nucleic acids and proteins and methods for making and using them |
EP2540831A3 (en) * | 2006-08-17 | 2013-04-10 | Monsanto Technology, LLC | Transgenic plants with enhanced agronomic traits |
EP2175714A4 (en) * | 2007-07-10 | 2011-01-26 | Monsanto Technology Llc | Transgenic plants with enhanced agronomic traits |
ES2958266T3 (en) * | 2014-01-31 | 2024-02-06 | Enginzyme Ab | Procedure to catalyze an enzyme-catalyzed reaction |
BR112019012215A2 (en) * | 2016-12-14 | 2019-11-12 | Bonumose Llc | enzymatic production of d-alulose |
DE102017002252A1 (en) * | 2017-03-08 | 2018-09-13 | André Pick | Enzymatic process for the production of fructose |
KR20190128681A (en) * | 2017-03-13 | 2019-11-18 | 보너모스 엘엘씨 | Enzymatic Preparation of Hexose |
KR20180111667A (en) * | 2017-03-31 | 2018-10-11 | 씨제이제일제당 (주) | A composition for preparing tagatose and Methods for producing tagatose using The Same |
EP3867393A4 (en) * | 2018-10-19 | 2022-08-24 | Bonumose, Inc. | Enzymatic production of tagatose |
WO2020092315A1 (en) * | 2018-10-29 | 2020-05-07 | Bonumose Llc | Enzymatic production of hexoses |
US20220127653A1 (en) * | 2019-02-12 | 2022-04-28 | Bonumose, Inc. | Enzymatic production of mannose |
CN112626060B (en) * | 2019-10-09 | 2022-05-13 | 中国科学院天津工业生物技术研究所 | Immobilized multienzyme system for producing inositol and method for producing inositol |
-
2020
- 2020-07-17 JP JP2022502510A patent/JP2022541471A/en active Pending
- 2020-07-17 CA CA3143852A patent/CA3143852A1/en active Pending
- 2020-07-17 MX MX2022000381A patent/MX2022000381A/en unknown
- 2020-07-17 CN CN202080065138.3A patent/CN114599786A/en active Pending
- 2020-07-17 BR BR112022000699A patent/BR112022000699A2/en unknown
- 2020-07-17 KR KR1020227005195A patent/KR20220035460A/en unknown
- 2020-07-17 EP EP20841623.0A patent/EP3999636A4/en active Pending
- 2020-07-17 WO PCT/US2020/042562 patent/WO2021011881A1/en unknown
-
2022
- 2022-02-10 CO CONC2022/0001348A patent/CO2022001348A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20220035460A (en) | 2022-03-22 |
JP2022541471A (en) | 2022-09-26 |
EP3999636A4 (en) | 2023-09-20 |
CN114599786A (en) | 2022-06-07 |
WO2021011881A1 (en) | 2021-01-21 |
MX2022000381A (en) | 2022-04-06 |
EP3999636A1 (en) | 2022-05-25 |
CO2022001348A2 (en) | 2022-05-20 |
BR112022000699A2 (en) | 2022-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3143852A1 (en) | Immobilized enzyme compositions for the production of hexoses | |
CN107208084B (en) | The enzyme' s catalysis of D-Tag | |
AU2019373147A1 (en) | Enzymatic production of hexoses | |
JP2010504082A (en) | Method for producing 2-O-glyceryl-α-D-glucopyranoside | |
EP3924473A1 (en) | Enzymatic production of mannose | |
US20240200109A9 (en) | Immobilized enzyme compositions for the production of hexoses | |
Kovaleva et al. | Inulinase immobilization on macroporous anion-exchange resins by different methods | |
CN114657170B (en) | Preparation method of high-stability immobilized enzyme | |
Mahmoud | Immobilization of invertase by a new economical method using wood sawdust waste | |
KR102357124B1 (en) | Method for preparing immobilized allulose epimerase | |
CN112626060B (en) | Immobilized multienzyme system for producing inositol and method for producing inositol | |
US20230183768A1 (en) | Enzymatic production of allulose | |
Vaz et al. | Ion exchange chromatography for enzyme immobilization | |
JP6678483B2 (en) | Method for producing oligosaccharide | |
US20210388404A1 (en) | Enzymatic production of tagatose | |
KR101765684B1 (en) | Composition for producing phosphorylated tagatose from phosphorylated fructose derivative comprising Fructose 1,6-bisphosphate aldolase from Caldicellulosiruptor sp. as effective component | |
Dragomirescu et al. | Stabilization of enzymes for biotechnological applications | |
JPWO2021011881A5 (en) | ||
JP2024096353A (en) | Enzymatic production of hexoses | |
Shimidzu et al. | Synthesis and properties of cationic polynucleotide analog binding RNase A. | |
JPS6156084A (en) | Enzymatic reaction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20220914 |
|
EEER | Examination request |
Effective date: 20220914 |
|
EEER | Examination request |
Effective date: 20220914 |
|
EEER | Examination request |
Effective date: 20220914 |
|
EEER | Examination request |
Effective date: 20220914 |